Citations

Clear

1031 citation(s) found for "Clark, AS".

Lay health worker as interventionist training: reflective writing in US family health promotion practice
Meiers, Sonja J. , Dyce, Evan, Clark, Matthew M. , Hanza, Marcelo M. K., Bronars, Carrie, Nigon, Julie A., Sia, Irene G. , Sia, Irene G , Wieland, Mark L. , Patten, Christi A.

Mayo Clinic

Health Promotion International | December 3, 2020 | Volume: 36 | Issue: 6 | Pages: 1739-1752

10.1093/heapro/daaa143 | PMID 33619566 Get It

Summary Lay health worker-led health promotion interventions are well received within racial and ethnic minority communities. Increasing numbers of trained lay health workers will be needed to meet global health goals. The purpose of this process evaluation was to gain insights about how lay health worker as interventionists used theory-based approaches within a nutrition and physical activity health behavior change intervention in a clinical trial enrolling immigrant and refugee families. Data were comprised of ongoing reflective writing statements from four health workers about their implementation of the intervention. Using content analysis three themes emerged: (i) encouraging setting of small, family focused and relevant goals, (ii) being flexible in content delivery and (iii) being personally transformed (i.e. gained a sense of meaning from their experience). Lay health worker interventionist reflections on practice revealed they delivered the intervention within the primacy of the family partnering relationship by attending to unique family needs, and adjusting educational content and goal setting accordingly. Our results provide guidance for training and process evaluation of lay health worker intervention delivery in ethnically and racially diverse populations. Incorporating real-time reflection upon what was learned about skills of facilitating family motivation and family confidence enhanced affective learning and may be useful in future research studies and health promotion practice. The processes identified including setting small goals, flexibility and personal transformation could be considered in future lay health worker-delivered health promotion interventions.
Avoidable Acute Care Use Associated with Nausea and Vomiting Among Patients Receiving Highly Emetogenic Chemotherapy or Oxaliplatin
Navari, Rudolph M. , Ruddy, Kathryn J. , LeBlanc, Thomas W. , Clark-Snow, Rebecca, Binder, G. , Bailey, William L., Schmerold, Luke, Papademetriou, Eros , Roeland, Eric , Schmerold, Luke M , Leblanc, Thomas , Roeland, Eric J , Nipp, Ryan David , Schwartzberg, Lee Steven , Potluri, Ravi C.

Mayo Clinic

The Oncologist | December 2, 2020 | Volume: 26 | Issue: 4 | Pages: 325-331

10.1002/onco.13620 | PMID 33289268 Get It

Abstract Purpose Chemotherapy-induced nausea and vomiting (CINV) contributes to avoidable acute care, a metric now tracked in Medicare's oncology outcome measure. CINV is preventable, yet guidelines are often not followed. We sought to quantify acute care involving CINV and other avoidable toxicities after highly emetogenic chemotherapy (HEC) to identify excess risk and assess clinician adherence to antiemesis guidelines for HEC. Materials and Methods We retrospectively evaluated U.S. electronic health records (2012-2018) using Medicare's OP-35 outcome measure to identify avoidable acute care involving any of 10 toxicities, including CINV, after HEC regimens relative to non-HEC. Antiemetic guideline adherence was defined as use ofneurokinin-1 (NKl) receptor antagonists Q5 (RAs) plus 5-hydroxytryptamine type 3 RA+ dexamethasone at HEC initiation. Results Among 17,609 patients receiving HEC, acute care rates associated with HEC chemotherapy included 32% cisplatin, 31% carboplatin, and 21% anthracycline/cyclosphospharnide (AC), with 76% meeting the criteria as avoidable events. Oxaliplatin rates were 29%. Avoidable acute care occurred 1.83 times (95% confidence interval, 1.76-1.91, p < .0001) as often after HEC versus non-HEC excluding oxaliplatin; CINV-related acute care occurred 2.29 times as often. Nonadherence to antiemesis guidelines occurred in 34% and 24% of cisplatin and AC courses, respectively, because of omission of a NKl RA. Conclusions Patients treated with HEC regimens experienced high avoidable acute care use, 1.8 times the risk seen for other chemotherapy. Nonadherence to guideline-directed antiemetic prophylaxis highlights the need to ensure adherence to antiemetic guidelines, including the use of NKl RA in HEC. Implications for Practice After survival, perhaps the most important goal in oncology is limiting avoidable acute care, a goal now used by Medicare to impact cancer reimbursement. This study found that patients treated with highly emetogenic chemotherapy (HEC) regimens had high rates of avoidable acute care use, 1.8 times the risk seen for other chemotherapy. A substantial proportion of the avoidable acute care involved chemotherapy-induced nausea and vomiting. Results showed that incomplete adherence to national antiemetic guidelines for HEC regimens primarily driven by omission of upfront neurokinin-1 receptor antagonist use, suggesting that improved adherence can meaningfully resolve this gap in quality and cost of care.
Brain volumetric deficits in MAPT mutation carriers: a multisite study
Chu, Stephanie A. , Flagan, Taru , Staffaroni, Adam M. , Jiskoot, Lize C. , Deng, Jersey, Sturm, Virginia E. , Yokoyama, Jennifer S. , Papma, Janne M. , Geschwind, Dan, Rosen, Howard J. , Boxer, Adam L. , Heuer, Hilary W. , Forsberg, Leah K. , Brushaber, Danielle , Coppola, Giovanni , Bordelon, Yvette , Faber, Kelley , Feldman, Howard , Fields, Julie A. , Gavrilova, Ralitza H. , Ghoshal, Nupur , Graff‐Radford, Neill R. , Hsiung, Ging‐Yuek Robin , Huey, Edward D. , Kantarci, Kejal , Kaufer, Daniel , Karydas, Anna M., Kornak, John , Kramer, Joel H. , Kukull, Walter A. , Mackenzie, Ian R. , Mendez, Mario F. , Miller, Bruce L. , Onyike, Chiadi U. , Pantelyat, Alexander , Rademakers, Rosa , Ramos, Eliana Marisa , Roberson, Erik D. , Tartaglia, Maria Carmela , Tatton, Nadine , Toga, Arthur W. , Vetor, Ashley, Weıntraub, Sandra , Wong, Bonnie , Lee, Suzee E. , Brushaber, Danielle E, Kantarci, Kejal , Knopman, David S. , Lee, Suzee E , Hsiung, Gink-Yuek , Roberson, Erik , Miller, Bruce L , Pantelyat, Alex , Tartaglia, Maria Carmela , Yokoyama, Jennifer , Feldman, Howard H , Jiskoot, Lize C , Spina, Salvatore , Zhang, Liwen , Seeley, William W. , Boeve, Bradley F. , Grossman, Murray , Dickerson, Bradford Clark , Fong, Jamie , Foroud, Tatiana , Irwin, David J. , Knopman, David S. , Lapid, Maria I. , Litvan, Irene , Wszołek, Zbigniew K. , Swieten, John C. van

Mayo Clinic

Annals of Clinical and Translational Neurology | November 28, 2020 | Volume: 8 | Issue: 1 | Pages: 95-110

10.1002/acn3.51249 | PMID 33247623 Get It

AbstractObjectiveMAPT mutations typically cause behavioral variant frontotemporal dementia with or without parkinsonism. Previous studies have shown that symptomatic MAPT mutation carriers have frontotemporal atrophy, yet studies have shown mixed results as to whether presymptomatic carriers have low gray matter volumes. To elucidate whether presymptomatic carriers have lower structural brain volumes within regions atrophied during the symptomatic phase, we studied a large cohort of MAPT mutation carriers using a voxelwise approach.MethodsWe studied 22 symptomatic carriers (age 54.7 ± 9.1, 13 female) and 43 presymptomatic carriers (age 39.2 ± 10.4, 21 female). Symptomatic carriers’ clinical syndromes included: behavioral variant frontotemporal dementia (18), an amnestic dementia syndrome (2), Parkinson’s disease (1), and mild cognitive impairment (1). We performed voxel‐based morphometry on T1 images and assessed brain volumetrics by clinical subgroup, age, and mutation subtype.ResultsSymptomatic carriers showed gray matter atrophy in bilateral frontotemporal cortex, insula, and striatum, and white matter atrophy in bilateral corpus callosum and uncinate fasciculus. Approximately 20% of presymptomatic carriers had low gray matter volumes in bilateral hippocampus, amygdala, and lateral temporal cortex. Within these regions, low gray matter volumes emerged in a subset of presymptomatic carriers as early as their thirties. Low white matter volumes arose infrequently among presymptomatic carriers.InterpretationA subset of presymptomatic MAPT mutation carriers showed low volumes in mesial temporal lobe, the region ubiquitously atrophied in all symptomatic carriers. With each decade of age, an increasing percentage of presymptomatic carriers showed low mesial temporal volume, suggestive of early neurodegeneration.
Remote Monitoring of Cancer Patient Participation in a 12-Week Online Yoga Study: Challenges and Directions for Future Research
Eckert, Ryan , Huberty, Jennifer , Clark, Shannon , Huberty, Jennifer , Kosiorek, Heidi , Clark-Sienkiewicz, Shannon, Larkey, Linda , Mesa, Ruben A.

Mayo Clinic

Journal for the Measurement of Physical Behaviour | November 17, 2020 | Volume: 3 | Issue: 4 | Pages: 338-345

10.1123/jmpb.2019-0051 Get It

Introduction: The delivery of online interventions in cancer patients/survivors has increased. The measurement of participation in online interventions is important to consider, namely, the challenges of the remote assessment of activity. The purpose of this study was to report the measures used to assess intervention compliance and other physical activity participation in two online yoga studies, the relationship between the multimethod measures used, and the ability of cancer patients to complete these measures. Methods: The methods described are of two online yoga studies (feasibility and pilot). Cancer patients were asked to participate in 60 min/week of online yoga for 12 weeks, complete a weekly yoga log, wear a Fitbit daily for 12 weeks, and complete a weekly physical activity log. Finally, Clicky®, a web analytics software, was used to track online yoga participation. Results: Eighty-four people participated across both studies, with 63/84 participating in online yoga, averaging 57.5 ± 33.2 min/week of self-reported yoga participation compared to 41.4 ± 26.1 min/week of Clicky® yoga participation (Lin concordance = 0.28). All 84 participants averaged 95.5 ± 111.8 min/week of self-reported moderate/vigorous physical activity compared with 98.1 ± 115.9 min/week of Fitbit-determined moderate/vigorous physical activity (Lin concordance = 0.33). Across both studies, 82.9% of the yoga logs were completed, the Fitbit was worn on 75.2% of the days, and 78.7% of the physical activity logs were completed. Conclusions: Weak relationships between self-report and objective measures were demonstrated, but the compliance rates were above 75% for the study measures. Future research is needed, investigating the intricacies of self-report physical activity participation in remote interventions and the validation of a gold standard measurement for online interventions.
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
Ahluwalia, Manmeet S. , Baehring, Joachim M. , Brem, Henry , Butowski, Nicholas , Campian, Jian , Clark, Stephen W. , Fabiano, Andrew J. , Hattangadi‐Gluth, Jona A. , Holdhoff, Matthias , Junck, Larry , Kumthekar, Priya , Loeffler, Jay S., Mrugała, Maciej M. , Nagpal, Seema , Pandey, Manjari , Peters, Katherine B. , Robins, Ian, Rockhill, Jason K., Rusthoven, Chad G. , Shonka, Nicole , Shrieve, Dennis C. , Swinnen, Lode J., Weiss, Stephanie E. , Wen, Patrick Y. , Willmarth, Nicole E. , Bergman, Mary Anne, Darlow, Susan, Peters, Katherine B , Ahluwalia, Manmeet S , Nagpal, Seema , Nabors, Burt , Portnow, Jana , Brem, Steven , Forsyth, Peter A , Horbinski, Craig , Kaley, Thomas , Parney, Ian F. , Puduvalli, Vinay K. , Wen, Patrick Yung

Mayo Clinic

Journal of the National Comprehensive Cancer Network | November 5, 2020 | Volume: 18 | Issue: 11 | Pages: 1537-1570

10.6004/jnccn.2020.0052 | PMID 33152694 Get It

The NCCN Guidelines for Central Nervous System (CNS) Cancers focus on management of adult CNS cancers ranging from noninvasive and surgically curable pilocytic astrocytomas to metastatic brain disease. The involvement of an interdisciplinary team, including neurosurgeons, radiation therapists, oncologists, neurologists, and neuroradiologists, is a key factor in the appropriate management of CNS cancers. Integrated histopathologic and molecular characterization of brain tumors such as gliomas should be standard practice. This article describes NCCN Guidelines recommendations for WHO grade I, II, III, and IV gliomas. Treatment of brain metastases, the most common intracranial tumors in adults, is also described.
Thermal Ablation Techniques Provide Safe and Effective Treatment of Primary Papillary Thyroid Microcarcinoma
Clark, Jennifer , Stan, Marius N.

Mayo Clinic

Clinical Thyroidology | October 6, 2020 | Volume: 32 | Issue: 10 | Pages: 474-476

10.1089/ct.2020;32.474-476 Get It

Mindfulness-Based Cognitive Therapy, Acceptance and Commitment Therapy, and Positive Psychotherapy for Major Depression
Seshadri, Ashok , Orth, Scott S. , Adaji, Akuh, Singh, Balwinder , Clark, Matthew M. , Frye, Mark A. , McGillivray, Jane, Fuller-Tyszkiewicz, Matthew, Singh, Balwinder , McGillivray, Jane , Fuller‐Tyszkiewicz, Matthew

Mayo Clinic

American Journal of Psychotherapy | September 28, 2020 | Volume: 74 | Issue: 1 | Pages: 4-12

10.1176/appi.psychotherapy.20200006 | PMID 32985916 Get It

Depressive symptoms and myeloproliferative neoplasms: Understanding the confounding factor in a complex condition
Padrnos, Leslie , Scherber, Robyn M. , Geyer, Holly L. , Langlais, Blake, Dueck, Amylou C. , Senyak, Zhenya, Clark, Matthew M. , Boxer, Michael , Cotter, Mary, Harrison, Claire , Stonnington, Cynthia M. , Geda, Yonas E. , Geyer, Holly, Langlais, Blake T., Clark, Matthew , Stonnington, Cynthia, Geda, Yonas, Dueck, A. C. , Geda, Yonas E , Kosiorek, Heidi , Mesa, Ruben A.

Mayo Clinic

Cancer Medicine | September 25, 2020 | Volume: 9 | Issue: 22 | Pages: 8301-8309

10.1002/cam4.3380 | PMID 32976697 Get It

AbstractBackgroundPhiladelphia chromosome negative myeloproliferative neoplasms (MPNs), including essential thrombocythemia, polycythemia vera, and myelofibrosis, have severe function‐limiting symptom burden that is experienced by the majority of patients. Previous studies have suggested that depression may be present in over a quarter of MPN patients, but to date no studies have evaluated the relationship between depression and other variables such as symptoms.MethodsA 70‐item internet based survey regarding fatigue and mood symptoms was developed by a multidisciplinary team of MPN investigators, patients and patient advocates including Patient Health Questionnaire and the Myeloproliferative Neoplasm Symptom Assessment Form was completed by over 1300 patients with MPN diagnosis.ResultsThere were 309 respondents (23%) with PHQ‐2 scores ≥ 3. In this analysis, we found worse systemic symptom burden in individuals reporting depressive symptoms.ConclusionThis analysis suggests the importance of depression in contributing to as well as confounding symptomatology in MPN patients, and suggests that this critical variable should also be addressed by clinicians and researchers alike when comprehensively assessing symptom burden etiologies.
Cardiac Abnormalities Seen in Pediatric Patients During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: An International Experience
Clark, Bradley C. , Sánchez-de-Toledo, Joan , Bautista-Rodríguez, Carles , Choueiter, Nadine , Lara, Diego, Kang, Hechaan, Fraisse, Alain , César, Sergi , Shaikh, Abdul Sattar , Escobar‐Diaz, Maria C. , Randanne, Paula C. , Kleinmahon, Jake , Lamour, Jacqueline M. , Johnson, Jonathan N. , Chowdhury, Devyani , Mohsin, Shazia , Hsu, Daphne T. , Aslam, Nadeem, Sarquella-Brugada, Georgia

Mayo Clinic

Journal of the American Heart Association | September 22, 2020 | Volume: 9 | Issue: 21 | Pages: No page available

10.1161/jaha.120.018007 | PMID 32957826 Get It

Background During the severe acute respiratory syndrome Coronavirus 2 pandemic, there has been an increase in hyperinflammatory presentation in previously healthy children with a variety of cardiac manifestations. Our objective is to describe the cardiac manifestations found in an international cohort of 55 pediatric cases with multi‐system inflammatory syndrome during the severe acute respiratory syndrome Coronavirus 2 pandemic. Methods and Results We reviewed data on previously healthy pediatric patients (≤18 years) with structurally normal hearts who presented at hospitals in the United States, United Kingdom, Spain, and Pakistan with multi‐system inflammatory syndrome in children and had consultation with a pediatric cardiologist. Data collected included demographics, clinical presentation, laboratory values, electrocardiographic abnormalities, echocardiographic findings, and initial therapies. A total of 55 patients presented with multi‐system inflammatory syndrome in children. Thirty‐five patients (64%) had evidence of decreased left ventricular function, 17 (31%) had valvulitis, 12 (22%) with pericardial effusion, and 11 (20%) with coronary abnormalities. Twenty‐seven (49%) required intensive care unit admission and 24 (44%) had evidence of shock. Eleven patients (20%) fulfilled complete Kawasaki disease criteria and had lower NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide), D‐dimer, and ferritin levels compared with those who did not fulfill criteria. Electrophysiologic abnormalities occurred in 6 patients and included complete atrioventricular block, transient atrioventricular block, and ventricular tachycardia. Conclusions To our knowledge, we describe the first international cohort of pediatric patients with multi‐system inflammatory syndrome in children during the severe acute respiratory syndrome Coronavirus 2 pandemic with a range of cardiac manifestations. This article brings awareness and alertness to the global medical community to recognize these children during the pandemic and understand the need for early cardiology evaluation and follow‐up.